Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Eruptive xanthomas associated with olanzapine use.

Eruptive xanthomas associated with olanzapine use. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Eruptive xanthomas associated with olanzapine use. Abstract Text:

    BACKGROUND: Since their introduction to the US market, atypical antipsychotic drugs, such as olanzapine, have been widely prescribed for the management of psychosis and have increasingly been used in dermatologic settings for the treatment of psychogenic dermatoses. Mild hyperglycemia and hypertriglyceridemia have been documented from the use of these medications, but the range of effects on metabolism and the effects on skin are poorly characterized. OBSERVETION: We describe 3 patients who developed eruptive xanthomas, 1 of whom had relative insulin insufficiency, after starting olanzapine therapy. These cases further support the association of severe dyslipidemia with olanzapine use in selected patients. CONCLUSION: With the increasing use of atypical antipsychotic agents in the dermatologic setting, the dyslipidemia that develops in association with olanzapine use emphasizes the need for periodic metabolic studies in high-risk patients.

    Eruptive xanthomas associated with olanzapine use. Publishing Authors By Initials

    For similar nutritional and metabolic diseases: metabolic diseases: lipid metabolism disorders: xanthomatosis research abstracts see: nutritional and metabolic diseases: metabolic diseases: lipid metabolism disorders: xanthomatosis research

    PUBMED ID PMID:

    MEDLINE DATE:

    Eruptive xanthomas associated with olanzapine use. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Archives of dermatology

    VOLUME: 139

    Page Numbers: 1045-8

    Journal Abbreviation: Arch Dermatol

    ISSN: 0003-987X

    DAY: 17

    MONTH: Aug

    YEAR: 2003

    Eruptive xanthomas associated with olanzapine use. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 372433

    Eruptive xanthomas associated with olanzapine use. Keywords Mesh Terms:

    KEYWORDS: Xanthomatosis

    MESH TERMS: pathology

    Chemical & Substance for Abstract: Eruptive xanthomas associated with olanzapine use. Information

    Substance Name: Pirenzepine

    Registry Number: 28797-61-7

    Grant and Affiliation Information for Eruptive xanthomas associated with olanzapine use.

    AFFILIATION: Department of Dermatology, Program in Epithelial Biology, Stanford University School of Medicine, Stanford, Calif. 94305, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Arch Dermatol

    REFSOURCE: Arch Dermatol. 2004 May;140(5):617-8

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Eruptive xanthomas associated with olanzapine use Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News